ReLIA Diagnostic Systems, Inc. has developed a low-cost, high-performance, portable immunoassay system for Point-of-Care (POC) that provides the sensitivity, precision, accuracy and reliability of expensive and complex central laboratory system, with the advantage of onsite testing by non-technical personnel (CLIA-waivable). ReLIA is designed specifically to meet the needs and requirements of the POCT environment that requires rapid, quantitative testing of whole blood samples or other body fluids, without prior processing. The timely results, superior data management, connectivity, improved convenience, and cost effectiveness characterize the ReLIA system. ReLIA's headquarters are located in San Francisco, California. The company has a technology development center in Burlingame, California, and a product development and manufacturing center in Shenzhen, China. The manufacturing center has received both GMP certification and ISO13485.